Foundation Medicine And WuXi PharmaTech Announce Strategic Collaboration To Offer Best-in-Class Comprehensive Genomic Profiling in China

By: via Benzinga
Foundation Medicine, Inc. (NASDAQ: FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced a collaboration to offer Foundation ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.